ARNA insider filings
ARENA PHARMACEUTICALS INC — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-03-11. Screen ARNA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ARNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — ARENA PHARMACEUTICALS INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-03-11 | 4 | Knobil Katharine — Director | Other (J): 2,939 · Other (J): 3,882 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 7,202 (derivative) | EDGAR |
| 2022-03-11 | 4 | Nova Tina Susan — Director | Other (J): 17,776 · Other (J): 3,067 · Disposition to issuer (D): 4,800 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 more | EDGAR |
| 2022-03-11 | 4 | FETZER OLIVER — Director | Other (J): 1,525 · Other (J): 8,167 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 more | EDGAR |
| 2022-03-11 | 4 | GALLAHUE KIERAN — Director | Other (J): 3,628 · Other (J): 1,116 · Other (J): 8,167 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 4,583 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 more | EDGAR |
| 2022-03-11 | 4 | Jarrett Jennifer — Director | Other (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 more | EDGAR |
| 2022-03-11 | 4 | NEIL GARRY ARTHUR — Director | Other (J): 8,150 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 more | EDGAR |
| 2022-03-11 | 4 | Schoch Steven J — Director | Other (J): 4,600 · Disposition to issuer (D): 3,601 (derivative) · Disposition to issuer (D): 7,202 (derivative) | EDGAR |
| 2022-03-11 | 4 | Dallas Jayson Donald Alexander — Director | Other (J): 4,085 · Other (J): 3,067 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,167 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +3 more | EDGAR |
| 2022-03-11 | 4 | Ouzren Nawal — Director | Other (J): 890 · Other (J): 3,665 · Disposition to issuer (D): 2,500 (derivative) · Disposition to issuer (D): 1,666 (derivative) · Disposition to issuer (D): 7,202 (derivative) | EDGAR |
| 2022-03-11 | 4 | Manion Douglas J. — EVP Research & Development | Other (J): 15,000 · Other (J): 21,462 · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 15,200 (derivative) | EDGAR |
| 2022-03-11 | 4 | Stelzer Laurie — EVP & Chief Financial Officer | Other (J): 9,086 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 132,000 (derivative) · Disposition to issuer (D): 38,850 (derivative) · Disposition to issuer (D): 15,200 (derivative) | EDGAR |
| 2022-03-11 | 4 | Munshi Amit — President and CEO, Director | Gift (G): 10,500 @ $98.51 · Other (J): 250 · Other (J): 28,800 · Other (J): 85,847 · Disposition to issuer (D): 138,139 (derivative) · Disposition to issuer (D): 56,861 (derivative) · +5 more | EDGAR |
| 2022-03-11 | 4 | Schmidt Joan — EVP, General Counsel & Sec | Other (J): 8,165 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 132,000 (derivative) · Disposition to issuer (D): 38,850 (derivative) · Disposition to issuer (D): 15,200 (derivative) | EDGAR |
| 2022-03-11 | 4 | Aurentz Vincent — Executive VP and CBO | Other (J): 27,842 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 77,000 (derivative) · Disposition to issuer (D): 94,976 (derivative) · +4 more | EDGAR |
| 2022-03-11 | 4 | Lisicki Robert — EVP, Chief Commercial Officer | Other (J): 9,441 · Other (J): 6,660 · Other (J): 21,462 · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 70,000 (derivative) · +2 more | EDGAR |
| 2022-01-05 | 4 | Schmidt Joan — EVP, General Counsel & Sec | Grant/award (A): 21,462 @ $0 | EDGAR |
| 2022-01-05 | 4 | Manion Douglas J. — EVP Research & Development | Grant/award (A): 21,462 @ $0 | EDGAR |
| 2022-01-05 | 4 | Munshi Amit — President and CEO, Director | Grant/award (A): 85,847 @ $0 | EDGAR |
| 2022-01-05 | 4 | Stelzer Laurie — EVP & Chief Financial Officer | Grant/award (A): 21,462 @ $0 | EDGAR |
| 2022-01-05 | 4 | Lisicki Robert — EVP, Chief Commercial Officer | Grant/award (A): 21,462 @ $0 | EDGAR |
| 2022-01-05 | 4 | Aurentz Vincent — Executive VP and CBO | Grant/award (A): 21,462 @ $0 | EDGAR |
| 2021-08-17 | 4 | Manion Douglas J. — EVP Research & Development | Grant/award (A): 15,000 @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2021-08-17 | 4 | Munshi Amit — President and CEO, Director | Purchase (P): 1,000 @ $48.19 | EDGAR |
| 2021-08-13 | 4 | Munshi Amit — President and CEO, Director | Purchase (P): 1,000 @ $50.41 | EDGAR |
| 2021-08-11 | 4 | Munshi Amit — President and CEO, Director | Purchase (P): 1,000 @ $52.91 | EDGAR |
| 2021-08-05 | 4 | Lisicki Robert — EVP, Chief Commercial Officer | Option exercise (M): 17,500 @ $40.95 · Sale (S): 5,605 @ $59.84 · Sale (S): 11,895 @ $60.20 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Knobil Katharine — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Dallas Jayson Donald Alexander — Director | Grant/award (A): 3,067 @ $0 · Sale (S): 1,223 @ $66.36 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | GALLAHUE KIERAN — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | FETZER OLIVER — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Ouzren Nawal — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Nova Tina Susan — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Jarrett Jennifer — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Schoch Steven J — Director | Grant/award (A): 1,533 @ $0 · Grant/award (A): 3,067 @ $0 · Grant/award (A): 3,601 (derivative) @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | NEIL GARRY ARTHUR — Director | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Stelzer Laurie — EVP & Chief Financial Officer | Option exercise (M): 12,600 @ $0 · Tax withholding (F): 4,356 @ $76.10 · Option exercise (M): 12,600 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Schmidt Joan — EVP, General Counsel & Sec | Option exercise (M): 12,600 @ $0 · Tax withholding (F): 4,874 @ $77.58 · Option exercise (M): 12,600 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Schmidt Joan — EVP, General Counsel & Sec | Grant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Lisicki Robert — EVP, Chief Commercial Officer | Grant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Aurentz Vincent — Executive VP and CBO | Grant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Stelzer Laurie — EVP & Chief Financial Officer | Grant/award (A): 6,660 @ $0 · Grant/award (A): 38,850 (derivative) @ $0 · Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Munshi Amit — President and CEO, Director | Grant/award (A): 28,800 @ $0 · Grant/award (A): 168,000 (derivative) @ $0 · Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Ouzren Nawal — Director | Grant/award (A): 893 @ $0 · Grant/award (A): 595 @ $0 · Grant/award (A): 2,500 (derivative) @ $0 · Grant/award (A): 1,666 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Aurentz Vincent — Executive VP and CBO | Option exercise (M): 2,500 @ $14.60 · Option exercise (M): 24 @ $35.60 · Sale (S): 2,524 @ $85 · Option exercise (M): 2,500 (derivative) @ $0 · Option exercise (M): 24 (derivative) @ $0 | EDGAR |
| 2021-02-04 | 4 | Lisicki Robert — EVP, Chief Commercial Officer | Option exercise (M): 17,500 @ $40.95 · Sale (S): 1,741 @ $77.70 · Sale (S): 6,400 @ $78.50 · Sale (S): 9,359 @ $79.35 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2021-02-04 | 4/A | Lisicki Robert — EVP, Chief Commercial Officer | Holdings only — no transactions reported | EDGAR |
| 2021-01-20 | 4 | Dallas Jayson Donald Alexander — Director | Sale (S): 1,327 @ $80.50 | EDGAR |
| 2021-01-20 | 4 | Munshi Amit — President and CEO, Director | Option exercise (M): 50,000 @ $15.50 · Sale (S): 47,100 @ $80.19 · Sale (S): 2,900 @ $81.06 · Option exercise (M): 50,000 @ $15.50 · Sale (S): 50,000 @ $80.14 · Option exercise (M): 50,000 (derivative) @ $0 · +1 more | EDGAR |
| 2021-01-14 | 4 | Munshi Amit — President and CEO, Director | Sale (S): 2,000 @ $73.90 · Sale (S): 7,481 @ $75.07 · Sale (S): 5,396 @ $75.64 | EDGAR |
| 2021-01-11 | 4 | Munshi Amit — President and CEO, Director | Option exercise (M): 23,400 @ $0 · Tax withholding (F): 8,523 @ $77.59 · Option exercise (M): 23,400 (derivative) @ $0 | EDGAR |
Recent 8-K events — ARENA PHARMACEUTICALS INC
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-03-11 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-03-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-02-23 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-02-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2022-02-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-01-07 | 8-K | 8.01 — Other Events | EDGAR |
| 2021-12-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2021-06-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ARNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs